As per the article published by Mr. Sandeep Rathod on http://genericpharmaceuticals.blogspot.com/
Natco has received a stay from the Supreme Court against the Chennai High Courts’ order for the IPAB hearing of Novartis’ appeals [for Imatinib] without a technical member.
The Chennai High Court had earlier decided that the IPAB could hear an appeal without a technical member.
Natco had then declared that it would go to the Supreme Court to against this decision for the constitution of the Bench comprising its Chairman and Vice-Chairman to hear the appeals, without a technical member
No comments:
Post a Comment